SCHEMBL22266263

SCHEMBL22266263

OCCOCCCCc1ccon1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
THRB P10828 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 2/20 0.34
MAPK1 P28482 2/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
CASP1 P29466 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
KCNH3 Q9ULD8 1/20 0.31
NPC1 O15118 1/20 0.30
PKM P14618 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22266322 0.98 MEN1 (0.38) MEN1KMT2ATHRBHTTMAPT
SCHEMBL22266299 0.95 TSHR (0.35) MEN1KMT2ATHRBHTTMAPT
SCHEMBL22266284 0.93 NPC1 (0.30) NPC1PKMCYP1A2CYP2D6CYP19A1
SCHEMBL22266280 0.90 CYP1A2 (0.30) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL22266310 0.88 CYP1A2 (0.31) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL20235114 0.88 MAPK1 (0.37) MEN1KMT2ATSHRMAPK1USP2
SCHEMBL22266265 0.87 CYP1A2 (0.30) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL22266282 0.86 MEN1 (0.39) MEN1KMT2ATSHRMAPK1USP2
SCHEMBL22266238 0.85 GAA (0.33) MEN1KMT2ATHRBHTTMAPT
SCHEMBL22266270 0.85 CYP1A2 (0.31) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139458-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS ARVINAS OPERATIONS, INC. 2021-05-13 US disclosed
US-10723717-B2 Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides ARVINAS OPERATIONS, INC. (US) 2020-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139458-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS MDM2, CRBN, VHL MEN1 2168/4885KMT2A 1473/4885THRB 1449/4885
US-10723717-B2 Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides CRBN, ARAF, VHL MEN1 2317/4885KMT2A 1975/4885THRB 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.